CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS DEFICIT (UNAUDITED) - USD ($)	Total	Series A Preferred Stocks [Member]	Series B, Preferred Stock	Common Stock	Common Stock To Be Issued	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Jun. 30, 2023		757,395	1,000,000	389,433,144
Balance, amount at Jun. 30, 2023	$ (6,620,100)	$ 8	$ 10	$ 3,894	$ 51,950	$ 19,789,793	$ (23,638,461)	$ (2,827,294)
Conversion of Series A Preferred to Common Stock, shares		(5,000)		5,000,000
Conversion of Series A Preferred to Common Stock, amount	0	$ 0	0	$ 50	0	(50)	0	0
Conversion of convertible notes payable and accrued interest into common stock, shares				6,600,000
Conversion of convertible notes payable and accrued interest into common stock, amount	66,000	0	0	$ 66	0	65,934	0	0
Net loss	(342,012)	$ 0	$ 0	$ 0	0	0	(334,090)	(7,922)
Balance, shares at Sep. 30, 2023		752,395	1,000,000	401,033,144
Balance, amount at Sep. 30, 2023	(6,896,112)	$ 8	$ 10	$ 4,010	51,950	19,855,677	(23,972,551)	(2,835,216)
Balance, shares at Jun. 30, 2023		757,395	1,000,000	389,433,144
Balance, amount at Jun. 30, 2023	(6,620,100)	$ 8	$ 10	$ 3,894	51,950	19,789,793	(23,638,461)	(2,827,294)
Net loss	(1,933,003)
Balance, shares at Mar. 31, 2024		723,895	1,000,000	455,044,644
Balance, amount at Mar. 31, 2024	(8,165,329)	$ 7	$ 10	$ 4,550	51,950	20,176,912	(25,548,061)	(2,850,697)
Balance, shares at Sep. 30, 2023		752,395	1,000,000	401,033,144
Balance, amount at Sep. 30, 2023	(6,896,112)	$ 8	$ 10	$ 4,010	51,950	19,855,677	(23,972,551)	(2,835,216)
Conversion of Series A Preferred to Common Stock, shares		(18,500)		18,500,000
Conversion of Series A Preferred to Common Stock, amount	(1)	$ (1)	0	$ 185	0	(185)	0	0
Conversion of convertible notes payable and accrued interest into common stock, shares				25,511,500
Conversion of convertible notes payable and accrued interest into common stock, amount	255,115	0	0	$ 255	0	254,860	0	0
Net loss	(1,206,895)	$ 0	$ 0	$ 0	0	0	(1,199,183)	(7,712)
Balance, shares at Dec. 31, 2023		733,895	1,000,000	445,044,644
Balance, amount at Dec. 31, 2023	(7,847,893)	$ 7	$ 10	$ 4,450	51,950	20,110,352	(25,171,734)	2,842,928
Conversion of Series A Preferred to Common Stock, shares		(10,000)		10,000,000
Conversion of Series A Preferred to Common Stock, amount	0	$ 0	0	$ 100	0	(100)	0	0
Net loss	(384,096)	0	0	0	0	0	(376,327)	(7,769)
Warrants issued with convertible debt	66,660	$ 0	$ 0	$ 0		66,660	0	0
Balance, shares at Mar. 31, 2024		723,895	1,000,000	455,044,644
Balance, amount at Mar. 31, 2024	(8,165,329)	$ 7	$ 10	$ 4,550	51,950	20,176,912	(25,548,061)	(2,850,697)
Balance, shares at Jun. 30, 2024		705,895	1,000,000	524,853,304
Balance, amount at Jun. 30, 2024	(8,612,454)	$ 7	$ 10	$ 5,248	51,950	20,899,187	(26,708,915)	(2,859,941)
Conversion of Series A Preferred to Common Stock, shares		(6,479)		6,479,000
Conversion of Series A Preferred to Common Stock, amount	0	$ 0	0	$ 65	0	(65)	0	0
Conversion of convertible notes payable and accrued interest into common stock, shares				26,950,000
Conversion of convertible notes payable and accrued interest into common stock, amount	269,501	0	0	$ 270	0	269,231	0	0
Net loss	(372,222)	0	0	$ 0	0	0	(364,846)	(7,376)
Stock issued for services, shares				11,902,182
Stock issued for services, amount	217,512	$ 0	$ 0	$ 119	0	217,393	0	0
Balance, shares at Sep. 30, 2024		699,416	1,000,000	570,184,486
Balance, amount at Sep. 30, 2024	(8,497,663)	$ 7	$ 10	$ 5,702	51,950	21,385,746	(27,073,761)	(2,867,317)
Balance, shares at Jun. 30, 2024		705,895	1,000,000	524,853,304
Balance, amount at Jun. 30, 2024	(8,612,454)	$ 7	$ 10	$ 5,248	51,950	20,899,187	(26,708,915)	(2,859,941)
Net loss	(1,319,759)
Balance, shares at Mar. 31, 2025		672,116	1,000,000	681,131,059
Balance, amount at Mar. 31, 2025	(8,591,145)	$ 7	$ 10	$ 6,811	97,900	22,192,742	(28,011,467)	(2,877,148)
Balance, shares at Sep. 30, 2024		699,416	1,000,000	570,184,486
Balance, amount at Sep. 30, 2024	(8,497,663)	$ 7	$ 10	$ 5,702	51,950	21,385,746	(27,073,761)	(2,867,317)
Conversion of Series A Preferred to Common Stock, shares		(17,200)		17,200,000
Conversion of Series A Preferred to Common Stock, amount	0	$ 0	0	$ 172	0	(172)	0	0
Conversion of convertible notes payable and accrued interest into common stock, shares				16,500,000
Conversion of convertible notes payable and accrued interest into common stock, amount	210,950	0	0	$ 165	45,950	164,835	0	0
Net loss	(417,269)	0	0	$ 0	0	0	(410,050)	(7,219)
Stock issued for services, shares				967,000
Stock issued for services, amount	14,505	0	0	$ 10	0	14,495	0	0
Cashless exercise of warrants, shares				1,528,185
Cashless exercise of warrants, amount	0	$ 0	$ 0	$ 15	0	(15)	0	0
Balance, shares at Dec. 31, 2024		682,216	1,000,000	606,379,671
Balance, amount at Dec. 31, 2024	(8,689,477)	$ 7	$ 10	$ 6,064	97,900	21,564,889	(27,483,811)	(2,874,536)
Conversion of Series A Preferred to Common Stock, shares		(10,100)		10,100,000
Conversion of Series A Preferred to Common Stock, amount		$ 0	0	$ 101	0	(101)	0	0
Conversion of convertible notes payable and accrued interest into common stock, shares				62,088,888
Conversion of convertible notes payable and accrued interest into common stock, amount	578,600	0	0	$ 620	0	577,980	0	0
Net loss	(530,268)	0	0	$ 0	0	0	(527,656)	(2,612)
Stock issued for services, shares				2,562,500
Stock issued for services, amount	50,000	$ 0	$ 0	$ 26	0	49,974	0	0
Balance, shares at Mar. 31, 2025		672,116	1,000,000	681,131,059
Balance, amount at Mar. 31, 2025	$ (8,591,145)	$ 7	$ 10	$ 6,811	$ 97,900	$ 22,192,742	$ (28,011,467)	$ (2,877,148)

XERIANT, INC. 10-Q